{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:26:46Z","timestamp":1787905606344,"version":"build-2784847793"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Schizophr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The main objective of this review was to evaluate studies on the diagnosis, treatment, and course of schizotypal personality disorder and to provide a clinical guidance on the basis of that evaluation. A systematic search in the PubMed\/MEDLINE databases was conducted. Two independent reviewers extracted and assessed the quality of the data. A total of 54 studies were eligible for inclusion: 18 were on diagnostic instruments; 22, on pharmacological treatment; 3, on psychotherapy; and 13, on the longitudinal course of the disease. We identified several suitable and reliable questionnaires for screening (PDQ-4+ and SPQ) and diagnosing (SIDP, SIDP-R, and SCID-II) schizotypal personality disorder. Second-generation antipsychotics (mainly risperidone) were the most often studied drug class and were described as beneficial. Studies on the longitudinal course described a moderate remission rate and possible conversion rates to other schizophrenia spectrum disorders. Because of the heterogeneity of the studies and the small sample sizes, it is not yet possible to make evidence-based recommendations for treatment. This is a systematic evaluation of diagnostic instruments and treatment studies in schizotypal personality disorder. We conclude that there is currently only limited evidence on which to base treatment decisions in this disorder. Larger interventional trials are needed to provide the data for evidence-based recommendations.<\/jats:p>","DOI":"10.1038\/s41537-018-0062-8","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T06:02:17Z","timestamp":1537768937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Diagnosis and treatment of schizotypal personality disorder: evidence from a systematic review"],"prefix":"10.1038","volume":"4","author":[{"given":"Sophie K.","family":"Kirchner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Roeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Nolden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkomiet","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"62_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev.clinpsy.2.022305.095318","volume":"2","author":"A Raine","year":"2006","unstructured":"Raine, A. Schizotypal personality: neurodevelopmental and psychosocial trajectories. Annu. Rev. Clin. Psychol. 2, 291\u2013326 (2006).","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"62_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1017\/S0033291717001829","volume":"48","author":"E Fonseca-Pedrero","year":"2018","unstructured":"Fonseca-Pedrero, E. et al. The structure of schizotypal personality traits: a cross-national study. Psychol. Med. 48, 451\u2013462 (2018).","journal-title":"Psychol. Med."},{"key":"62_CR3","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/schbul\/sbm098","volume":"34","author":"TR Kwapil","year":"2008","unstructured":"Kwapil, T. R., Barrantes-Vidal, N. & Silvia, P. J. The dimensional structure of the Wisconsin Schizotypy Scales: factor identification and construct validity. Schizophr. Bull. 34, 444\u2013457 (2008).","journal-title":"Schizophr. Bull."},{"key":"62_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.schres.2017.07.001","volume":"193","author":"TR Kwapil","year":"2018","unstructured":"Kwapil, T. R., Gross, G. M., Silvia, P. J., Raulin, M. L. & Barrantes-Vidal, N. Development and psychometric properties of the Multidimensional Schizotypy Scale: a new measure for assessing positive, negative, and disorganized schizotypy. Schizophr. Res. 193, 209\u2013217 (2018).","journal-title":"Schizophr. Res."},{"issue":"Suppl 2","key":"62_CR5","doi-asserted-by":"publisher","first-page":"S374","DOI":"10.1093\/schbul\/sbu194","volume":"41","author":"OJ Mason","year":"2015","unstructured":"Mason, O. J. The assessment of schizotypy and its clinical relevance. Schizophr. Bull. 41(Suppl 2), S374\u2013S385 (2015).","journal-title":"Schizophr. Bull."},{"key":"62_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/archpsyc.1989.01810100077015","volume":"46","author":"PE Meehl","year":"1962","unstructured":"Meehl, P. E. Schizotaxia, schizotypy, schizophrenia. Arch. Gen. Psychiatry 46, 935\u2013944 (1962).","journal-title":"Arch. Gen. Psychiatry"},{"key":"62_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1521\/pedi.1990.4.1.1","volume":"4","author":"PE Meehl","year":"1990","unstructured":"Meehl, P. E. Toward an integrated theory of schizotaxia. J. Pers. Disord. 4, 1\u201399 (1990).","journal-title":"J. Pers. Disord."},{"key":"62_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/wps.20479","volume":"17","author":"MF Lenzenweger","year":"2018","unstructured":"Lenzenweger, M. F. Schizotypy, schizotypic psychopathology and schizophrenia. World Psychiatry 17, 25\u201326 (2018).","journal-title":"World Psychiatry"},{"key":"62_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/00005053-198411000-00007","volume":"172","author":"LJ Chapman","year":"1984","unstructured":"Chapman, L. J. et al. Impulsive nonconformity as a trait contributing to the prediction of psychotic-like and schizotypal symptoms. J. Nerv. Ment. Dis. 172, 681\u2013691 (1984).","journal-title":"J. Nerv. Ment. Dis."},{"issue":"Suppl 2","key":"62_CR10","doi-asserted-by":"publisher","first-page":"S366","DOI":"10.1093\/schbul\/sbu186","volume":"41","author":"TR Kwapil","year":"2015","unstructured":"Kwapil, T. R. & Barrantes-Vidal, N. Schizotypy: looking back and moving forward. Schizophr. Bull. 41(Suppl 2), S366\u2013S373 (2015).","journal-title":"Schizophr. Bull."},{"key":"62_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fpsyt.2014.00018","volume":"5","author":"U Ettinger","year":"2014","unstructured":"Ettinger, U., Meyhofer, I., Steffens, M., Wagner, M. & Koutsouleris, N. Genetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia. Front. Psychiatry 5, 18 (2014).","journal-title":"Front. Psychiatry"},{"key":"62_CR12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.7334\/psicothema2016.209","volume":"29","author":"EDM Fonseca-Pedero","year":"2017","unstructured":"Fonseca-Pedero, E. D. M. Schizotypal traits and psychotic-like experiences during adolescence: an update. Psicothema 29, 5\u201317 (2017).","journal-title":"Psicothema"},{"key":"62_CR13","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/sj.mp.4001996","volume":"12","author":"AH Fanous","year":"2007","unstructured":"Fanous, A. H. et al. Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy. Mol. Psychiatry 12, 958\u2013965 (2007).","journal-title":"Mol. Psychiatry"},{"key":"62_CR14","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3389\/fpsyg.2016.01769","volume":"7","author":"EE Walter","year":"2016","unstructured":"Walter, E. E., Fernandez, F., Snelling, M. & Barkus, E. Genetic consideration of schizotypal traits: a review. Front. Psychol. 7, 1769 (2016).","journal-title":"Front. Psychol."},{"key":"62_CR15","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3109\/09540261.2012.737313","volume":"24","author":"W Gaebel","year":"2012","unstructured":"Gaebel, W., Zielasek, J. & Cleveland, H. R. Classifying psychosis--challenges and opportunities. Int. Rev. Psychiatry 24, 538\u2013548 (2012).","journal-title":"Int. Rev. Psychiatry"},{"key":"62_CR16","unstructured":"World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines (World Health Organization, 2016) http:\/\/www.who.int\/classifications\/icd\/en\/bluebook.pdf."},{"key":"62_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4088\/PCC.08m00679","volume":"11","author":"AJ Pulay","year":"2009","unstructured":"Pulay, A. J. et al. Prevalence, correlates, disability, and comorbidity of DSM-IV schizotypal personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. Prim. Care. Companion J. Clin. Psychiatry 11, 53\u201367 (2009).","journal-title":"Prim. Care. Companion J. Clin. Psychiatry"},{"key":"62_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-014-0452-1","volume":"16","author":"DR Rosell","year":"2014","unstructured":"Rosell, D. R., Futterman, S. E., McMaster, A. & Siever, L. J. Schizotypal personality disorder: a current review. Curr. Psychiatry Rep. 16, 452 (2014).","journal-title":"Curr. Psychiatry Rep."},{"key":"62_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0022-3956(99)00023-0","volume":"34","author":"C Sobin","year":"2000","unstructured":"Sobin, C. et al. Evidence of a schizotypy subtype in OCD. J. Psychiatr. Res. 34, 15\u201324 (2000).","journal-title":"J. Psychiatr. Res."},{"key":"62_CR20","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1017\/S0033291714002669","volume":"45","author":"KS Kendler","year":"2015","unstructured":"Kendler, K. S. et al. A longitudinal twin study of cluster A personality disorders. Psychol. Med. 45, 1531\u20131538 (2015).","journal-title":"Psychol. Med."},{"key":"62_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0006-3223(02)01416-6","volume":"52","author":"RM Bilder","year":"2002","unstructured":"Bilder, R. M. et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol. Psychiatry 52, 701\u2013707 (2002).","journal-title":"Biol. Psychiatry"},{"key":"62_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/mp.2009.69","volume":"15","author":"M Nyegaard","year":"2010","unstructured":"Nyegaard, M. et al. CACNA1C (rs1006737) is associated with schizophrenia. Mol. Psychiatry 15, 119\u2013121 (2010).","journal-title":"Mol. Psychiatry"},{"key":"62_CR23","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1086\/425586","volume":"75","author":"CA Hodgkinson","year":"2004","unstructured":"Hodgkinson, C. A. et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am. J. Hum. Genet. 75, 862\u2013872 (2004).","journal-title":"Am. J. Hum. Genet."},{"issue":"Suppl 2","key":"62_CR24","doi-asserted-by":"publisher","first-page":"S396","DOI":"10.1093\/schbul\/sbu176","volume":"41","author":"M Debbane","year":"2015","unstructured":"Debbane, M. et al. Developing psychosis and its risk states through the lens of schizotypy. Schizophr. Bull. 41(Suppl 2), S396\u2013S407 (2015).","journal-title":"Schizophr. Bull."},{"key":"62_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/15622970701685224","volume":"8","author":"SC Herpertz","year":"2007","unstructured":"Herpertz, S. C. et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J. Biol. Psychiatry 8, 212\u2013244 (2007).","journal-title":"World J. Biol. Psychiatry"},{"key":"62_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. & Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 151, 264\u2013269 (2009). W264.","journal-title":"Ann. Intern. Med."},{"key":"62_CR27","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1176\/ajp.143.10.1222","volume":"143","author":"LB Jacobsberg","year":"1986","unstructured":"Jacobsberg, L. B., Hymowitz, P., Barasch, A. & Frances, A. J. Symptoms of schizotypal personality disorder. Am. J. Psychiatry 143, 1222\u20131227 (1986).","journal-title":"Am. J. Psychiatry"},{"key":"62_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1037\/0021-843X.95.1.43","volume":"95","author":"TA Widiger","year":"1986","unstructured":"Widiger, T. A., Frances, A., Warner, L. & Bluhm, C. Diagnostic criteria for the borderline and schizotypal personality disorders. J. Abnorm. Psychol. 95, 43\u201351 (1986).","journal-title":"J. Abnorm. Psychol."},{"key":"62_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/archpsyc.1987.01800140045007","volume":"44","author":"TH McGlashan","year":"1987","unstructured":"McGlashan, T. H. Testing DSM-III symptom criteria for schizotypal and borderline personality disorders. Arch. Gen. Psychiatry 44, 143\u2013148 (1987).","journal-title":"Arch. Gen. Psychiatry"},{"key":"62_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000284612","volume":"22","author":"P Vaglum","year":"1989","unstructured":"Vaglum, P., Friis, S., Vaglum, S. & Larsen, F. Comparison between personality disorder diagnoses in DSM-III and DSM-III-R: reliability, diagnostic overlap, predictive validity. Psychopathology 22, 309\u2013314 (1989).","journal-title":"Psychopathology"},{"key":"62_CR31","doi-asserted-by":"publisher","first-page":"s49","DOI":"10.1192\/bjp.187.48.s49","volume":"48","author":"P Handest","year":"2005","unstructured":"Handest, P. & Parnas, J. Clinical characteristics of first-admitted patients with ICD-10 schizotypal disorder. Br. J. Psychiatry Suppl. 48, s49\u2013s54 (2005).","journal-title":"Br. J. Psychiatry Suppl."},{"key":"62_CR32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/00005053-198411000-00006","volume":"172","author":"JC Perry","year":"1984","unstructured":"Perry, J. C., O\u2019Connell, M. E. & Drake, R. An assessment of the schedule for schizotypal personalities and the DSM-III criteria for diagnosing schizotypal personality disorder. J. Nerv. Ment. Dis. 172, 674\u2013680 (1984).","journal-title":"J. Nerv. Ment. Dis."},{"key":"62_CR33","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/archpsyc.1985.01790290073008","volume":"42","author":"D Stangl","year":"1985","unstructured":"Stangl, D., Pfohl, B., Zimmerman, M., Bowers, W. & Corenthal, C. A structured interview for the DSM-III personality disorders. A preliminary report. Arch. Gen. Psychiatry 42, 591\u2013596 (1985).","journal-title":"Arch. Gen. Psychiatry"},{"key":"62_CR34","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/schbul\/17.4.555","volume":"17","author":"A Raine","year":"1991","unstructured":"Raine, A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr. Bull. 17, 555\u2013564 (1991).","journal-title":"Schizophr. Bull."},{"key":"62_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/schbul\/23.1.83","volume":"23","author":"M Battaglia","year":"1997","unstructured":"Battaglia, M., Cavallini, M. C., Macciardi, F. & Bellodi, L. The structure of DSM-III-R schizotypal personality disorder diagnosed by direct interviews. Schizophr. Bull. 23, 83\u201392 (1997).","journal-title":"Schizophr. Bull."},{"key":"62_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/107319119800500307","volume":"5","author":"RD Merritt","year":"1998","unstructured":"Merritt, R. D., Balogh, D. W. & Kok, C. J. DSM-IV Cluster A personality disorder diagnoses among young adults with a 2-7-8 MMPI profile. Assessment 5, 273\u2013285 (1998).","journal-title":"Assessment"},{"key":"62_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/oxfordjournals.schbul.a006860","volume":"27","author":"A Fossati","year":"2001","unstructured":"Fossati, A. et al. Latent class analysis of DSM-IV schizotypal personality disorder criteria in psychiatric patients. Schizophr. Bull. 27, 59\u201371 (2001).","journal-title":"Schizophr. Bull."},{"key":"62_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.schres.2005.05.016","volume":"78","author":"CC Dickey","year":"2005","unstructured":"Dickey, C. C. et al. Clinical, cognitive, and social characteristics of a sample of neuroleptic-naive persons with schizotypal personality disorder. Schizophr. Res. 78, 297\u2013308 (2005).","journal-title":"Schizophr. Res."},{"key":"62_CR39","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1017\/S0033291715002226","volume":"46","author":"LC Morey","year":"2016","unstructured":"Morey, L. C., Benson, K. T. & Skodol, A. E. Relating DSM-5 section III personality traits to section II personality disorder diagnoses. Psychol. Med. 46, 647\u2013655 (2016).","journal-title":"Psychol. Med."},{"key":"62_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1034\/j.1600-0447.2002.0_479.x","volume":"105","author":"CA Sanislow","year":"2002","unstructured":"Sanislow, C. A. et al. Confirmatory factor analysis of DSM-IV borderline, schizotypal, avoidant and obsessive-compulsive personality disorders: findings from the Collaborative Longitudinal Personality Disorders Study. Acta Psychiatr. Scand. 105, 28\u201336 (2002).","journal-title":"Acta Psychiatr. Scand."},{"key":"62_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/00005053-198711000-00006","volume":"175","author":"TH McGlashan","year":"1987","unstructured":"McGlashan, T. H. Recovery style from mental illness and long-term outcome. J. Nerv. Ment. Dis. 175, 681\u2013685 (1987).","journal-title":"J. Nerv. Ment. Dis."},{"key":"62_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1521\/pedi.15.2.168.19219","volume":"15","author":"SR Axelrod","year":"2001","unstructured":"Axelrod, S. R., Grilo, C. M., Sanislow, C. & McGlashan, T. H. Schizotypal Personality Questionnaire-Brief: factor structure and convergent validity in inpatient adolescents. J. Pers. Disord. 15, 168\u2013179 (2001).","journal-title":"J. Pers. Disord."},{"key":"62_CR43","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1521\/pedi.2007.21.6.626","volume":"21","author":"AG Ryder","year":"2007","unstructured":"Ryder, A. G., Costa, P. T. & Bagby, R. M. Evaluation of the SCID-II personality disorder traits for DSM-IV: coherence, discrimination, relations with general personality traits, and functional impairment. J. Pers. Disord. 21, 626\u2013637 (2007).","journal-title":"J. Pers. Disord."},{"key":"62_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.psychres.2005.02.008","volume":"137","author":"A Fossati","year":"2005","unstructured":"Fossati, A. et al. Taxonic structure of schizotypal personality disorder: a multiple-instrument, multi-sample study based on mixture models. Psychiatry Res. 137, 71\u201385 (2005).","journal-title":"Psychiatry Res."},{"key":"62_CR45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1046\/j.1440-1819.2002.01034.x","volume":"56","author":"M Matsui","year":"2002","unstructured":"Matsui, M., Sumiyoshi, T., Niu, L., Kurokawa, K. & Kurachi, M. Minnesota Multiphasic Personality Inventory profile characteristics of schizotypal personality disorder. Psychiatry Clin. Neurosci. 56, 443\u2013452 (2002).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"62_CR46","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/archpsyc.1992.01820110026003","volume":"49","author":"L Baer","year":"1992","unstructured":"Baer, L. et al. Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Arch. Gen. Psychiatry 49, 862\u2013866 (1992).","journal-title":"Arch. Gen. Psychiatry"},{"key":"62_CR47","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1001\/archpsyc.1986.01800070070009","volume":"43","author":"SC Goldberg","year":"1986","unstructured":"Goldberg, S. C. et al. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. Arch. Gen. Psychiatry 43, 680\u2013686 (1986).","journal-title":"Arch. Gen. Psychiatry"},{"key":"62_CR48","first-page":"342","volume":"23","author":"SC Goldberg","year":"1987","unstructured":"Goldberg, S. C., Schulz, S. C., Resnick, R. J., Hamer, R. M. & Schulz, P. M. Differential prediction of response to thiothixene and placebo in borderline and schizotypal personality disorders. Psychopharmacol. Bull. 23, 342\u2013346 (1987).","journal-title":"Psychopharmacol. Bull."},{"key":"62_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0920-9964(00)00059-1","volume":"48","author":"RM Kirrane","year":"2001","unstructured":"Kirrane, R. M., Mitropoulou, V., Nunn, M., Silverman, J. & Siever, L. J. Physostigmine and cognition in schizotypal personality disorder. Schizophr. Res. 48, 1\u20135 (2001).","journal-title":"Schizophr. Res."},{"key":"62_CR50","doi-asserted-by":"publisher","first-page":"628","DOI":"10.4088\/JCP.v64n0602","volume":"64","author":"HW Koenigsberg","year":"2003","unstructured":"Koenigsberg, H. W. et al. Risperidone in the treatment of schizotypal personality disorder. J. Clin. Psychiatry 64, 628\u2013634 (2003).","journal-title":"J. Clin. Psychiatry"},{"key":"62_CR51","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.biopsych.2006.06.034","volume":"61","author":"MM McClure","year":"2007","unstructured":"McClure, M. M. et al. The effects of guanfacine on context processing abnormalities in schizotypal personality disorder. Biol. Psychiatry 61, 1157\u20131160 (2007).","journal-title":"Biol. Psychiatry"},{"key":"62_CR52","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/npp.2010.5","volume":"35","author":"MM McClure","year":"2010","unstructured":"McClure, M. M. et al. Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum. Neuropsychopharmacology 35, 1356\u20131362 (2010).","journal-title":"Neuropsychopharmacology"},{"key":"62_CR53","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/JCP.0b013e3181accfd9","volume":"29","author":"MM McClure","year":"2009","unstructured":"McClure, M. M. et al. The effects of risperidone on the cognitive performance of individuals with schizotypal personality disorder. J. Clin. Psychopharmacol. 29, 396\u2013398 (2009).","journal-title":"J. Clin. Psychopharmacol."},{"key":"62_CR54","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.nicl.2016.05.019","volume":"11","author":"M Rabella","year":"2016","unstructured":"Rabella, M. et al. Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism. Neuroimage Clin. 11, 770\u2013779 (2016).","journal-title":"Neuroimage Clin."},{"key":"62_CR55","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/npp.2014.192","volume":"40","author":"DR Rosell","year":"2015","unstructured":"Rosell, D. R. et al. Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder. Neuropsychopharmacology 40, 446\u2013453 (2015).","journal-title":"Neuropsychopharmacology"},{"key":"62_CR56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0920-9964(95)00002-X","volume":"20","author":"BV Siegel","year":"1996","unstructured":"Siegel, B. V. et al. D-amphetamine challenge effects on Wisconsin Card Sort Test. Performance in schizotypal personality disorder. Schizophr. Res. 20, 29\u201332 (1996).","journal-title":"Schizophr. Res."},{"key":"62_CR57","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1176\/ajp.141.11.1455","volume":"141","author":"G Serban","year":"1984","unstructured":"Serban, G. & Siegel, S. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Am. J. Psychiatry 141, 1455\u20131458 (1984).","journal-title":"Am. J. Psychiatry"},{"key":"62_CR58","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0010-440X(86)90001-5","volume":"27","author":"P Hymowitz","year":"1986","unstructured":"Hymowitz, P., Frances, A., Jacobsberg, L. B., Sickles, M. & Hoyt, R. Neuroleptic treatment of schizotypal personality disorders. Compr. Psychiatry 27, 267\u2013271 (1986).","journal-title":"Compr. Psychiatry"},{"key":"62_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0165-1781(00)00203-1","volume":"96","author":"F Bogetto","year":"2000","unstructured":"Bogetto, F., Bellino, S., Vaschetto, P. & Ziero, S. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial. Psychiatry Res. 96, 91\u201398 (2000).","journal-title":"Psychiatry Res."},{"key":"62_CR60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.schres.2003.12.008","volume":"71","author":"M Keshavan","year":"2004","unstructured":"Keshavan, M., Shad, M., Soloff, P. & Schooler, N. Efficacy and tolerability of olanzapine in the treatment of schizotypal personality disorder. Schizophr. Res. 71, 97\u2013101 (2004).","journal-title":"Schizophr. Res."},{"key":"62_CR61","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1176\/ajp.148.8.1064","volume":"148","author":"PJ Markovitz","year":"1991","unstructured":"Markovitz, P. J., Calabrese, J. R., Schulz, S. C. & Meltzer, H. Y. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am. J. Psychiatry 148, 1064\u20131067 (1991).","journal-title":"Am. J. Psychiatry"},{"key":"62_CR62","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/01.jcp.0000095352.32154.e1","volume":"23","author":"JK Rybakowski","year":"2003","unstructured":"Rybakowski, J. K., Drozdz, W. & Borkowska, A. Low dose risperidone in the treatment of schizophrenia-like symptoms in high-risk subjects. J. Clin. Psychopharmacol. 23, 674\u2013675 (2003).","journal-title":"J. Clin. Psychopharmacol."},{"key":"62_CR63","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1037\/1064-1297.15.6.569","volume":"15","author":"R Di Lorenzo","year":"2007","unstructured":"Di Lorenzo, R. et al. Aripiprazole: effectiveness and safety under naturalistic conditions. Exp. Clin. Psychopharmacol. 15, 569\u2013575 (2007).","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"62_CR64","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0033-3182(98)71349-0","volume":"39","author":"Z Gutkovich","year":"1998","unstructured":"Gutkovich, Z., Rosenthal, R. N. & Bogdonoff, L. Transient psychosis with psychogenic polydipsia in schizotypal patient taking fluoxetine. Psychosomatics 39, 295\u2013296 (1998).","journal-title":"Psychosomatics"},{"key":"62_CR65","first-page":"179","volume":"23","author":"A Heiden","year":"1998","unstructured":"Heiden, A., de Zwaan, M., Frey, R., Presslich, O. & Kasper, S. Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder. J. Psychiatry Neurosci. 23, 179\u2013180 (1998).","journal-title":"J. Psychiatry Neurosci."},{"key":"62_CR66","first-page":"219","volume":"45","author":"M Poyurovsky","year":"2008","unstructured":"Poyurovsky, M. Clozapine in treatment-refractory obsessive-compulsive disorder with comorbid schizotypal personality disorder. Isr. J. Psychiatry Relat. Sci. 45, 219\u2013220 (2008).","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"62_CR67","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/00004583-199409000-00011","volume":"33","author":"KJ Zwier","year":"1994","unstructured":"Zwier, K. J. & Rao, U. Buspirone use in an adolescent with social phobia and mixed personality disorder (cluster A type). J. Am. Acad. Child Adolesc. Psychiatry 33, 1007\u20131011 (1994).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"62_CR68","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2006.01.002","volume":"83","author":"M Nordentoft","year":"2006","unstructured":"Nordentoft, M. et al. Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophr. Res. 83, 29\u201340 (2006).","journal-title":"Schizophr. Res."},{"key":"62_CR69","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/00005053-199204000-00005","volume":"180","author":"S Karterud","year":"1992","unstructured":"Karterud, S. et al. Day hospital therapeutic community treatment for patients with personality disorders. An empirical evaluation of the containment function. J. Nerv. Ment. Dis. 180, 238\u2013243 (1992).","journal-title":"J. Nerv. Ment. Dis."},{"key":"62_CR70","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0005-7916(96)00010-9","volume":"27","author":"D McKay","year":"1996","unstructured":"McKay, D. & Neziroglu, F. Social skills training in a case of obsessive-compulsive disorder with schizotypal personality disorder. J. Behav. Ther. Exp. Psychiatry 27, 189\u2013194 (1996).","journal-title":"J. Behav. Ther. Exp. Psychiatry"},{"key":"62_CR71","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/0010-440X(85)90081-1","volume":"26","author":"EM Plakun","year":"1985","unstructured":"Plakun, E. M., Burkhardt, P. E. & Muller, J. P. 14-year follow-up of borderline and schizotypal personality disorders. Compr. Psychiatry 26, 448\u2013455 (1985).","journal-title":"Compr. Psychiatry"},{"key":"62_CR72","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/archpsyc.1986.01800040039006","volume":"43","author":"TH McGlashan","year":"1986","unstructured":"McGlashan, T. H. Schizotypal personality disorder. Chestnut Lodge follow-up study: VI. Long-term follow-up perspectives. Arch. Gen. Psychiatry 43, 329\u2013334 (1986).","journal-title":"Arch. Gen. Psychiatry"},{"key":"62_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000284574","volume":"22","author":"J Modestin","year":"1989","unstructured":"Modestin, J., Foglia, A. & Toffler, G. Comparative study of schizotypal and schizophrenic patients. Psychopathology 22, 1\u201313 (1989).","journal-title":"Psychopathology"},{"key":"62_CR74","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1600-0447.1991.tb01423.x","volume":"84","author":"L Mehlum","year":"1991","unstructured":"Mehlum, L. et al. Personality disorders 2-5 years after treatment: a prospective follow-up study. Acta Psychiatr. Scand. 84, 72\u201377 (1991).","journal-title":"Acta Psychiatr. Scand."},{"key":"62_CR75","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1176\/appi.ajp.158.2.295","volume":"158","author":"DS Bender","year":"2001","unstructured":"Bender, D. S. et al. Treatment utilization by patients with personality disorders. Am. J. Psychiatry 158, 295\u2013302 (2001).","journal-title":"Am. J. Psychiatry"},{"key":"62_CR76","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1037\/0022-006X.72.5.767","volume":"72","author":"CM Grilo","year":"2004","unstructured":"Grilo, C. M. et al. Two-year stability and change of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders. J. Consult. Clin. Psychol. 72, 767\u2013775 (2004).","journal-title":"J. Consult. Clin. Psychol."},{"key":"62_CR77","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1037\/0021-843X.113.2.217","volume":"113","author":"MB Warner","year":"2004","unstructured":"Warner, M. B. et al. The longitudinal relationship of personality traits and disorders. J. Abnorm. Psychol. 113, 217\u2013227 (2004).","journal-title":"J. Abnorm. Psychol."},{"key":"62_CR78","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1176\/appi.ajp.162.5.883","volume":"162","author":"TH McGlashan","year":"2005","unstructured":"McGlashan, T. H. et al. Two-year prevalence and stability of individual DSM-IV criteria for schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders: toward a hybrid model of axis II disorders. Am. J. Psychiatry 162, 883\u2013889 (2005).","journal-title":"Am. J. Psychiatry"},{"key":"62_CR79","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1176\/ajp.150.8.1237","volume":"150","author":"DP Bernstein","year":"1993","unstructured":"Bernstein, D. P. et al. Prevalence and stability of the DSM-III-R personality disorders in a community-based survey of adolescents. Am. J. Psychiatry 150, 1237\u20131243 (1993).","journal-title":"Am. J. Psychiatry"},{"key":"62_CR80","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/schbul\/23.1.93","volume":"23","author":"SS Olin","year":"1997","unstructured":"Olin, S. S. et al. Childhood behavior precursors of schizotypal personality disorder. Schizophr. Bull. 23, 93\u2013103 (1997).","journal-title":"Schizophr. Bull."},{"key":"62_CR81","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/cap.2005.15.395","volume":"15","author":"JR Asarnow","year":"2005","unstructured":"Asarnow, J. R. Childhood-onset schizotypal disorder: a follow-up study and comparison with childhood-onset schizophrenia. J. Child Adolesc. Psychopharmacol. 15, 395\u2013402 (2005).","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"62_CR82","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/schbul\/sbp027","volume":"35","author":"SW Woods","year":"2009","unstructured":"Woods, S. W. et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr. Bull. 35, 894\u2013908 (2009).","journal-title":"Schizophr. Bull."},{"key":"62_CR83","doi-asserted-by":"crossref","unstructured":"Farooq, S., et al. Pharmacological interventions for schizotypal personality disorder. Cochrane Database Syst. Rev. CD009047 (2011).","DOI":"10.1002\/14651858.CD009047"}],"container-title":["npj Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-018-0062-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-018-0062-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-018-0062-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:14:44Z","timestamp":1755616484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-018-0062-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1038\/s41537-018-0062-8","relation":{},"ISSN":["2334-265X"],"issn-type":[{"value":"2334-265X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,3]]},"assertion":[{"value":"5 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the past 5 years, A.H. received a paid speakership from Desitin, Otsuka, Janssen-Cilag, and Lundbeck. He was previously member of an advisory boards of Roche, Otsuka, Lundbeck, and Janssen-Cilag. The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}